Literature DB >> 16920210

Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models.

Slavka Lukacova1, Jens Overgaard, Jan Alsner, Michael R Horsman.   

Abstract

PURPOSE: To investigate the relationship between tumour hypoxia and serum and tumour osteopontin (OPN) levels.
MATERIALS AND METHODS: Experiments were performed in CDF1 or C3H/Km mice implanted with a C3H mammary carcinoma (CDF1) or SCCVII squamous cell carcinoma (C3H/Km), respectively. Mice were either untreated or gassed with 10% oxygen for 1-72 h. Serum and tumour OPN levels were measured with an ELISA and tumour OPN mRNA levels using RT-PCR. Tumour oxygenation was estimated using the Eppendorf histograph with the percentage of pO(2) values <or=5 mm Hg (HF5) as the endpoint.
RESULTS: OPN levels were 50-fold higher in the serum of non-tumour bearing CDF1 mice compared to C3H/Km mice. A tumour related increase in serum OPN levels was observed in CDF1 but not in C3H/Km mice. Low oxygen breathing increased HF5 in both tumour models and in the C3H mammary carcinoma model both serum and tumour OPN decreased after prolonged hypoxia (24h and more). When 12h of hypoxia was followed by 24h reoxygenation there was a twofold increase in serum OPN levels. No changes were observed in the SCCVII model. No changes in tumour OPN mRNA expression were observed during hypoxia and reoxygenation in these tumour models.
CONCLUSION: Clear strain and tumour specific differences in the effect of hypoxia on OPN levels have been observed in two different mouse tumour models. These data emphasize the complexity in the relationship between poor oxygenation (and/or reoxygenation) of tumours and serum levels of OPN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920210     DOI: 10.1016/j.radonc.2006.07.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  1 in total

1.  Influence of osteopontin silencing on survival and migration of lung cancer cells.

Authors:  B Polat; G Wohlleben; A Katzer; C S Djuzenova; A Technau; M Flentje
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.